Skip to main content
Clinical Trials/ACTRN12623000859684
ACTRN12623000859684
Recruiting
未知

Multi-Centre Registry for Oncological and Quality of Life Outcomes of Irreversible Electroporation (IRE) of Prostate Cancer

St Vincent's Private Hospital0 sites500 target enrollmentAugust 9, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Prostate Cancer
Sponsor
St Vincent's Private Hospital
Enrollment
500
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 9, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
Male

Investigators

Sponsor
St Vincent's Private Hospital

Eligibility Criteria

Inclusion Criteria

  • Patient 18 years and above
  • Is diagnosed with histologically confirmed prostate cancer
  • Is scheduled for IRE Nanoknife® regardless of previous treatments

Exclusion Criteria

  • No specific exclusion criteria are defined.

Outcomes

Primary Outcomes

Not specified

Similar Trials